Venclexta

venclexta multiple myeloma trial, venclexta trial results, venclexta label expansion, abbvie roche venclexta, venclexta progression free survival, venclexta blood cancer, venclexta failed endpoint,

Venclexta fails to meet primary endpoint in multiple myeloma trial

Anika Sharma

AbbVie and Roche, pioneers in the field of leukemia treatments with Venclexta, faced a setback as their hopes to expand ...